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ABSTRACT:
Cerebral venous sinus thrombosis is challenging condition because of its variability of underlying pathological causes. 
Numerous conditions can cause cerebral venous sinus thrombosis (CVST), and often more than one cause can be 
found in an individual patient. The causes leading to CVST can be classified into two broad categories; infective and 
non-infective. Among infective causes, chronic hepatitis C infection is considered as one of the extremely rare causes 
of cerebral venous sinus thrombosis.
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INTRODUCTION
Cerebral venous sinus thrombosis is one of the rare 
condition which nowadays is being diagnosed more 
frequently due to greater awareness and availability of 
better diagnostic modalities. Predisposing factors can 
be identified in up to 80% of the patients. [2]   The main 
predisposing conditions causing cerebral venous sinus 
thrombosis are either infectious (causing 8% of cases 
in a series) or noninfectious. [2] Among non-infectious 
causes, the connective tissue disorders, 
granulomatous or inflammatory disorders and 
malignancies are the most frequent causes. [3] In 
addition 20% to 35% of the cases have no identifiable 
cause. [4] We report case of a 32-year-old male with 
chronic hepatitis C virus infection as an infrequent 
cause of cerebral venous sinus thrombosis. [5-7]
CASE REPORT
A 32 years old male patient presented with history of 
headache for less than 2 weeks, history of one episode 
of transient blurring of vision 1 week ago. Afterward he 
had an episode of generalized tonic-clonic seizure 
followed by development of left hemiparesis. There was 
no history of hypertension, diabetes mellitus, or drug 
intoxication. He is a known case of Hepatitis C virus for 
3 months and is on anti-viral therapy Sofosbuvir and 
Velpatasvir for the past 3 months. On presentation his 
GCS was 8/15 (E3, M4, V1) with left sided weakness 
and a power of 3/5 in both upper and lower limbs. 
Cranial nerves and fundoscopy was normal. There were 
no signs of chronic liver disease on examination. His 
cardiovascular and respiratory examination was 
unremarkable. The initial laboratory tests including 
hematology, biochemistry and coagulation profile was 
normal. CT- brain was unremarkable. The initial 
laboratory tests including hematology, biochemistry and 
coagulation profile was normal. CT- brain was 
unremarkable. Magnetic resonance imaging (MRI) 
brain with Magnetic resonance venography (MRV) was 
done. MRI showed an infarct in right high parietal area 
(Figure. 1). MRV revealed superior sagittal sinus 
thrombosis (Figure 2). Antinuclear antibody (ANA) test 
was sent which came out negative.
Figure 1. MRI brain plain. 
Coronal FLAIR (A) and T2 weighted Axial (B) images 
showing hyper intense signal in right high Parietal 
parafalcine region.
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Thrombophilia workup turned out to be negative including Lupus anticoagulant, Factor V Leiden, Anti thrombin-III, 
Protein C and S and PCR for thrombin Gene mutation (G20210A) (Table 1). His general and neurological examination 
after six months of treatment was unremarkable with full recovery of left sided body weakness.
Table 1. THROMBOPHILIA SCREENING TESTS
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Figure 2. MRV brain.
MRV shows signal void in middle part of superior 
saggital sinus.
He was started treatment with anti-epileptics, 
anticoagulation and hydration. HCV PCR was repeated 
which was negative and antiviral drugs were stopped. 
Rivaroxaban was started in a dose of 15mg twice a day, 
which was later on switched to 20mg once a day after 
3 weeks. With initiation of treatment dramatic 
improvement was seen, GCS improved to 15/15 and 
power of left side of body improved to 4/5 in both upper 
and lower limbs. After completion of six months of 
treatment with Rivaroxaban his neuroimaging was 
repeated. MRI brain with MRV scan which showed 
optimal visualization of superior sagittal sinus and no 
evidence of dural sinus thrombosis (Figure 3 and 4).
Figure 3. MRI brain plain. 
T2 weighted Axial (A) and Coronal FLAIR (B) images 
showing resolution of lesion post therapy.
Figure 4. MRV brain.
MRV shows normal flow in all sinuses post therapy.
DISCUSSION
Cerebral venous sinus thrombosis results usually as a 
consequence of procoagulant conditions. [8] Cerebral 
venous sinus thrombosis has been described as a 
process of continued imbalance between 
prothrombotic and thrombolytic states, leading to 
progression of venous thrombosis with time. [2][ The 
mechanism by which cerebral venous sinus thrombosis 
occurs in patient with hepatitis B and C is not fully 
established, but it is thought that hepatitis is 
associated with formation of anti-cardiolipin antibodies. 
[9,10] Hence, the virus exclusively or in the combination 
with others such as anti-phospholipid syndrome results 
from formation of anti-cardiolipin antibodies during 
chronic hepatitis infection and can shift the delicate 
procoagulant/ thrombotic balance towards 
thrombosis.[7] However in our case anti-cardiolipin and 
other autoantibodies were negative. There are some 
data that suggest that HCV, itself might be responsible 
for thrombotic events.[6] It is hypothesized that protein 
that envelopes HCV has procoagulant activity and also 
virus genome that encodes for protein serine protease 
may have procoagulant activity. [11] In addition to that 
treatment used for HCV is capable of inducing variety of 
antibodies that also act as procoagulant. [12] Mostly this 
association is seen with INF-alpha drug. Since our 
patient was on sofosbusavir and velpatasvir, there is no 
documented data available for these two drugs that 
could possibly causing procoagulant state.
CONCLUSION
In conclusion, we suggest that Hepatitis C testing 
should be included in the investigation of unknown 
etiology of cerebral venous sinus thrombosis. Since our 
patient was known case of Hepatitis C and took oral 
antiviral therapy (sofosbusavir and velpatasvir) it is 
hypothesized that Hepatitis C virus uniquely is cause of 
cerebral venous sinus thrombosis.
P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S 4 0 V O L .  1 5  ( 3 )   J U LY- S E P  2 0 2 0
P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S 4 1
Conflict of interest: There is no conflict of interest.. 
Funding disclosure: Nil
Author’s contribution:
Haris Majid Rajput; data collection, data analysis, manuscript writing & review
Iqra Athar; manuscript writing, manuscript review 
Neelma Naz Khattak; data analysis, manuscript writing, manuscript review
Anam Anis; data analysis, manuscript writing, manuscript review 
Mazhar Badshah; data analysis, manuscript writing, manuscript review 
V O L .  1 5  ( 3 )   J U LY- S E P  2 0 2 0
References:
1. Bousser MG, Russell RR (1997) Cerebral venous 
thrombosis. (W B Saunders, London).
2.Villringer A, Mehraen S, Einhäupl KM (1994) 
Pathophysiological aspects of cerebral sinus 
venous thrombosis. J Neuroradiol 21:72–80
3. Ameri A, Bousser MG(1992) Cerebral venous 
thrombosis. Neurol Clin 10:87–111.
4. Marques MCP, Pires LA, Damasceno CA, Felício AC, 
Atala A, Franco GM. Trombose da veia de Galeno: 
relato de caso. Arq Neuropsiquiatr 
2003;61:285-287
5. Pawlotsky JM, Yahia MB, Andre C, et al. 
Immunological disorders in C virus chronic active 
hepatitis: a prospective case-control study. 
Hepatology 1994;19:841-848
6. Violi F, Ferro D, Basili. Hepatitis C virus, 
antiphospholipid antibodies, and thrombosis. 
Hepatology 1997;27:782
7. Nadir A, Amin A, Chalisa N, van Thiel DH. Retinal 
vein thrombosis associated with chronic hepatitis 
C: a case series and review of the literature. J Viral 
Hepat 2000;7:466-470.  
8. Beltrán-Blasco I. Trombosis venosas intracraneales. 
Rev Neurol 1997; 25:569-575.
9. Prieto J, Yuste JR, Beloqui O, et al. Anticardiolipin 
antibodies in chronic hepatitis C: implication of 
hepatitis C vírus as the cause of the 
antiphospholipid syndrome. Hepatology 
1996;23:199-204.   
     
 
10. Kesler A, Pomeranz IS, Huberman M, Novis B, Kott 
E. Cerebral venous thrombosis and chronic active 
hepatitis as a part of the antiphospholipid 
syndrome. Post Med J 1996;72:690-692.
   
11. Bezan JF, Fletterick RJ. Detection of a trypsin like 
serine protease domain in flaviviruses and 
pestiviruses. Virology 1989;171:637-639.
12. Saracco G, Touscoz A, Durazzo M. Auto antibodies 
and response to a-interferon in patients with 
chronic viral hepatitis. Hepatology 1990;11: 
339-343  
13. Sudhakar M Rao, Supriya Khardenavis, Aniurudda 
Deshpande, Suresh Pandi. Isolated vein of trolard 
thrombosis in an HBsAg- positive patient: case 
report. Medical Journal 2014;7:222-224
14. André Carvalho Felício, Márcia Maiumi Fukujima, et 
al. Cereberal venous thrombosis and hepatitis: 
case report. Arq. Neuro 2006;7
